Mariana Oncology

Acquired

Pioneering Novel Radioligand Therapeutics

United States · Founded 2021 · $250.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$250.0M
Last Round
$175.0M Series BSep 2023
Rounds
2
Acquired by
Novartis AGMay 2024

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Mariana Oncology, now a Novartis company, was a preclinical-stage biotechnology company focused on developing next-generation radioligand therapies (RLTs) to treat solid tumor cancers. The company built a portfolio of novel peptide-based radiopharmaceuticals designed to selectively deliver radioisotopes to diseased cells while minimizing damage to healthy tissue. Founded in 2021, Mariana raised $175M in a Series B round in 2023 before being acquired by Novartis for $1 billion in 2024.

Summary

Mariana Oncology is a Biotech company based in United States, founded in 2021. It has raised $250.0M in total across 2 rounds, most recently a $175.0M Series B round in Sep 2023. Investors include Atlas Venture, Novartis Venture Fund and Deep Track Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionMay 2024

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mariana Oncology on Indexed.vc
<a href="https://indexed.vc/companies/mariana-oncology"><img src="https://indexed.vc/api/badge/company/mariana-oncology" alt="Mariana Oncology on Indexed.vc" width="260" height="76" /></a>